Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $33.8400 (-7.64%) ($33.6800 - $37.5000) on Tue. Apr. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.42% (three month average) | RSI | 66 | Latest Price | $33.8400(-7.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.5% a day on average for past five trading days. | Weekly Trend | IOVA advances 6.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(46%) ARKG(45%) ARKK(41%) IWO(41%) | Factors Impacting IOVA price | IOVA will decline at least -4.21% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-13%) TBT(-5%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.21% (StdDev 8.42%) | Hourly BBV | 0 () | Intraday Trend | -8.8% | | | |
|
5 Day Moving Average | $36.18(-6.47%) | 10 Day Moving Average | $36.02(-6.05%) | 20 Day Moving Average | $33.36(1.44%) | To recent high | -12.9% | To recent low | 73.2% | Market Cap | $4.955b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |